Journal ArticleOPEN ACCESS

Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease

  • Chen Z
  • Wang X
  • Ye S
New England Journal of Medicine (2019) 381(3) 291-293
DOI: 10.1056/nejmc1900045
355Citations
Citations of this article
159Readers
Mendeley users who have this article in their library.

Abstract

Amyopathic Dermatomyositis–Related Lung Disease The autoimmune disease amyopathic dermatomyositis–associated interstitial lung disease, which is related to anti–melanoma differentiation–associated ...

Cite

CITATION STYLE

APA

Chen, Z., Wang, X., & Ye, S. (2019). Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease. New England Journal of Medicine, 381(3), 291–293. https://doi.org/10.1056/nejmc1900045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free